Medi Wings Bio Science Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
as on 16-07-2024
- Paid Up Capital ₹ 1.21 Cr
as on 16-07-2024
- Company Age 19 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 7.28 Cr
as on 16-07-2024
- Satisfied Charges ₹ 2.00 Cr
as on 16-07-2024
- Revenue -25.22%
(FY 2022)
- Profit -97.69%
(FY 2022)
- Ebitda -87.41%
(FY 2022)
- Net Worth 0.28%
(FY 2022)
- Total Assets -14.12%
(FY 2022)
About Medi Wings Bio Science
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 1.21 Cr.
The company currently has active open charges totaling ₹7.28 Cr. The company has closed loans amounting to ₹2.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sourabh Jain, Moolchand Porwar, Susheela Devi, and Two other members serve as directors at the Company.
- CIN/LLPIN
U70100KA2005PTC035390
- Company No.
035390
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Jan 2005
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Medi Wings Bio Science?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sourabh Jain  | Director | 11-Mar-2021 | Current |
| Moolchand Porwar | Director | 26-Nov-2011 | Current |
| Susheela Devi | Director | 06-Jan-2005 | Current |
| Vanitha | Director | 06-Jan-2005 | Current |
| Arvind Moolchand | Director | 06-Jan-2005 | Current |
Financial Performance of Medi Wings Bio Science.
Medi Wings Bio Science Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 25.22% decrease. The company also saw a substantial fall in profitability, with a 97.69% decrease in profit. The company's net worth moved up by a moderate rise of 0.28%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medi Wings Bio Science?
In 2022, Medi Wings Bio Science had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Karnataka State Financial Corporation Creation Date: 11 Oct 2019 | ₹4.78 Cr | Open |
Others Creation Date: 27 Apr 2013 | ₹2.50 Cr | Open |
Ing Vysya Bank Limited Creation Date: 23 Dec 2009 | ₹2.00 Cr | Satisfied |
How Many Employees Work at Medi Wings Bio Science?
Unlock and access historical data on people associated with Medi Wings Bio Science, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medi Wings Bio Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medi Wings Bio Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
